Soru

Zorluk: OrtaBias and Confounding in Research

Match each epidemiological scenario or study result with the specific research concept (bias or confounding) it best illustrates.

  • A new biomarker detects asymptomatic pancreatic cancer 18 months before standard imaging. Diagnosed patients show increased survival time from the date of detection, yet the overall population mortality rate for the disease remains unchanged.Lead-time bias
  • A voluntary prostate cancer screening initiative primarily identifies indolent, slow-growing tumors while missing rapidly aggressive variants, artificially inflating the apparent survival benefit of the program.Length-time bias
  • A retrospective review of a novel biologic for inflammatory bowel disease shows remarkable mucosal healing rates; however, clinicians preferentially prescribed this agent to patients with less severe baseline disease.Confounding by indication
  • Investigators analyzing the association between gastroesophageal reflux disease and osteoarthritis recruit all subjects solely from a tertiary hospital's inpatient wards, resulting in a distorted association due to dual admission probabilities.Berkson bias
  • In a study of a nephrotoxic antibiotic and hearing loss, the crude relative risk is 3.1. When researchers analyze the data separately by concurrent loop diuretic use, the relative risk is 1.0 in both the diuretic and non-diuretic subgroups.Confounding

Cevap

The biomarker scenario illustrates Lead-time bias, the prostate screening illustrates Length-time bias, the biologic therapy illustrates Confounding by indication, the hospital recruitment illustrates Berkson bias, and the antibiotic/diuretic scenario illustrates Confounding.
Each epidemiological scenario describes a specific mechanism that distorts the true association between an exposure and an outcome. Lead-time bias artificially increases survival time due to earlier detection. Length-time bias overestimates survival because slow-growing diseases are preferentially detected. Confounding by indication occurs when a treatment is given based on disease severity. Berkson bias is a selection bias arising from hospital admission rates. Classic confounding is revealed when subgroup stratification yields identical risks that differ from the overall crude risk.

Adım Adım Çözüm

1
Analyze the biomarker scenario
Identified Lead-time bias
The key feature is earlier detection without a change in overall mortality, artificially increasing the measured survival time.
2
Analyze the prostate screening scenario
Identified Length-time bias
The key feature is the disproportionate detection of indolent, slow-growing tumors, which skews survival statistics favorably.
3
Analyze the biologic therapy scenario
Identified Confounding by indication
The treatment assignment was directly tied to the baseline severity of the patients' disease, distorting the apparent efficacy.
4
Analyze the gastroesophageal reflux scenario
Identified Berkson bias
Recruiting exclusively from hospitalized patients introduces admission rate bias, a classic form of selection bias known as Berkson bias.
5
Analyze the antibiotic and hearing loss scenario
Identified Confounding
Because the relative risks in both subgroups are equal (1.0) but differ from the crude relative risk (3.1), the stratifying variable is a true confounder, not an effect modifier.

Anahtar Kavram

Distinguishing between various types of selection biases, information biases, and confounding in epidemiological studies based on their underlying mechanisms.
Bu soruyu puanla